Quantcast
Channel: EurekAlert! - Breaking News
Viewing all articles
Browse latest Browse all 3915

Efficacy and tolerability of a SPC of telmisartan/HCTZ in Chinese and Korean patients

$
0
0
Hypertension is an important issue in Asia. Prof. Zhu and Korean researchers found that in Chinese and Korean patients with moderate-to-severe hypertension, treatment with T80/H25 provided large reductions in mean SBP and DBP, and high BP goal attainment rates. This once-daily combination is effective and well tolerated in this patient group.

Viewing all articles
Browse latest Browse all 3915

Trending Articles